Rajendra Kristam

Title: Rajendra Kristam: Innovator in Pharmaceutical Compounds

Introduction

Rajendra Kristam is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical compounds, holding two patents that focus on innovative treatments for various medical conditions.

Latest Patents

His latest patents include the development of imidazo-pyridine compounds as PAD inhibitors. These compounds, along with their polymorphs, stereoisomers, prodrugs, solvates, co-crystals, intermediates, pharmaceutically acceptable salts, and metabolites, are designed to inhibit PAD4. They may be beneficial in treating disorders such as rheumatoid arthritis, vasculitis, systemic lupus erythematosus, ulcerative colitis, cancer, cystic fibrosis, asthma, multiple sclerosis, and psoriasis. Additionally, he has developed substituted pyrrolidine derivatives that inhibit the ATF4 pathway, which can be useful in treating cancer and diseases associated with activated unfolded protein response pathways, including Alzheimer's disease, spinal cord injury, and various cardiovascular diseases.

Career Highlights

Rajendra has worked with prominent companies such as Jubilant Epipad LLC and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.

Collaborations

He has collaborated with notable coworkers, including Gurulingappa Hallur and Athisayamani Jeyaraj Duraiswamy, further enhancing his contributions to the field.

Conclusion

Rajendra Kristam's work in developing innovative pharmaceutical compounds showcases his commitment to advancing medical treatments. His patents reflect a deep understanding of complex biochemical pathways and their implications for human health.